Show simple item record

dc.contributor.authorSingh, Kuljit
dc.contributor.authorCarson, Kristin
dc.contributor.authorRashid, Mohammed K
dc.contributor.authorJayasinghe, Rohan
dc.contributor.authorAlQahtani, Abdulrahman
dc.contributor.authorDick, Alexander
dc.contributor.authorGlover, Christopher
dc.contributor.authorLabinaz, Marino
dc.date.accessioned2019-06-07T01:40:33Z
dc.date.available2019-06-07T01:40:33Z
dc.date.issued2018
dc.identifier.issn1443-9506
dc.identifier.doi10.1016/j.hlc.2017.02.032
dc.identifier.urihttp://hdl.handle.net/10072/382307
dc.description.abstractBackground: Recent data from randomised and observational studies have reported non-inferior outcomes for transcatheter aortic valve implantation (TAVI) compared to surgical aortic valve replacement (SAVR) in intermediate-risk patients. We performed a systematic review to evaluate the mortality of TAVI compared to SAVR in intermediate-risk patients. Methods: A comprehensive search of four major databases (Embase, Ovid MEDLINE, PubMed, and Google Scholar) was performed from their inception to 29 April 2016. We included original research studies reporting data on TAVI and SAVR in intermediate-risk patients. We compared the outcomes of TAVI to SAVR. Results: A total of 2,375 and 2,377 intermediate-risk patients underwent TAVI and SAVR respectively. The 30-day all-cause (p = 0.07), 30-day cardiac (p = 0.53), and 12-month all-cause mortality (p = 0.34) was similar between the two groups. However, TAVI through transfemoral access had a significantly lower mortality than SAVR (OR 0.58, p = 0.006). The incidence of ≥moderate aortic incompetence (p < 0.00001) and pacemaker implantation (p < 0.0001) was higher in the TAVI group. Conclusions: In the intermediate-risk patients, the 30-day and 12-month mortality are similar between TAVI and SAVR. Increased operator experience and improved device technology have led to a significant reduction in mortality in intermediate-risk patients undergoing TAVI.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherElsevier Australia
dc.publisher.placeAustralia
dc.relation.ispartofpagefrom227
dc.relation.ispartofpageto234
dc.relation.ispartofissue2
dc.relation.ispartofjournalHeart, Lung and Circulation
dc.relation.ispartofvolume27
dc.subject.fieldofresearchCardiorespiratory Medicine and Haematology not elsewhere classified
dc.subject.fieldofresearchCardiorespiratory Medicine and Haematology
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode110299
dc.subject.fieldofresearchcode1102
dc.subject.fieldofresearchcode1117
dc.titleTranscatheter Aortic Valve Implantation in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: A Systematic Review and Meta-Analysis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.facultyGriffith Health, School of Medicine
gro.hasfulltextNo Full Text
gro.griffith.authorJayasinghe, Rohan
gro.griffith.authorSingh, Kuljit
gro.griffith.authorJayasinghe, Satyajit R.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record